Skip to Main Content

2023 STAT Summit

The 2023 STAT Summit is now complete

Thank you to the speakers and all who tuned in. Be sure to catch up with coverage from the event, and learn more about all of our upcoming events.

Speakers

Get inspired by the leading voices in the health tech and life science space

Noubar Afeyan, Ph.D.

Noubar Afeyan, Ph.D.

Founder and CEO, Flagship Pioneering

Priscilla Chan, M.D.

Virtual Speaker

Priscilla Chan, M.D.

Co-Founder and Co-CEO, Chan Zuckerberg Initiative

Michael J. Fox

Virtual Speaker

Michael J. Fox

Award-Winning Actor, Best-Selling Author, and Founder of the Michael J. Fox Foundation for Parkinson’s Research

Meghan O'Rourke

Meghan O’Rourke

Author of The Invisible Kingdom: Reimagining Chronic Illness

Daniel M. Skovronsky, M.D., Ph.D.

Daniel M. Skovronsky, M.D., Ph.D.

Executive Vice President, Chief Scientific and Medical Officer, and President, Lilly Research Laboratories, Eli Lilly and Company

Christopher A. Viehbacher

Christopher A. Viehbacher

President and Chief Executive Officer, Biogen

Emma Walmsley

Emma Walmsley

Chief Executive Officer, GSK

Mark Zuckerberg

Virtual Speaker

Mark Zuckerberg

Co-Founder and Co-CEO, Chan Zuckerberg Initiative

Zoe Adams, M.D.

Zoe Adams, M.D.

Resident Physician and Writer, Department of Medicine, Massachusetts General Hospital

Catherine Ames

Catherine Ames

Patient & Patient Advocate

Deborah W. Brooks

Virtual Speaker

Deborah W. Brooks

CEO and Co-Founder, The Michael J. Fox Foundation for Parkinson’s Research

Craig Bunnell, M.D.

Craig Bunnell, M.D.

Chief Medical Officer, Dana-Farber Cancer Institute

Ian Burkhart

Virtual Speaker

Ian Burkhart

Founder, BCI Pioneers Coalition

Brenda Cabrera-Mendoza, M.D., Ph.D.

Brenda Cabrera-Mendoza, M.D., Ph.D.

Postdoctoral Fellow, Yale University

Vlad Coric, M.D.

Vlad Coric, M.D.

Chairman and CEO, Biohaven

Athena Countouriotis, M.D.

Athena Countouriotis, M.D.

Co-Founder, Chief Executive Officer, Avenzo Therapeutics

Stacie Dusetzina, Ph.D.

Stacie Dusetzina, Ph.D.

Professor of Health Policy, Vanderbilt University School of Medicine

Aaron Ferguson

Aaron Ferguson

Leadership Team, Community Medical Services Research Committee and Outreach Manager, National Survivors Union

Amy Finkelstein, Ph.D.

Amy Finkelstein, Ph.D.

John & Jennie S. MacDonald Professor of Economics, MIT

Cynthia Fisher

Cynthia Fisher

Founder and Chairman, PatientRightsAdvocate.org

Angela Fitch, M.D.

Angela Fitch, M.D.

Co-Founder and Chief Medical Officer, knownwell

Monique Fitzgerald

Monique Fitzgerald

Community Advocate, Council Member of the Setalcott Nation, Co-Founder of the Brookhaven Landfill Action and Remediation Group

Lauren Ghazal, Ph.D.

Lauren Ghazal, Ph.D.

Assistant Professor, University of Rochester Medical Center

Laurie Glimcher, M.D.

Laurie Glimcher, M.D.

President and CEO, Dana-Farber Cancer Institute; Richard and Susan Smith Professor of Medicine, HMS

Faith Heeren

Virtual Speaker

Faith Heeren

Doctoral Candidate, University of Florida

Linda Henry

Linda Henry

CEO, Boston Globe Media Partners

Lotte Bjerre Knudsen, DMSc

Lotte Bjerre Knudsen, DMSc

Chief Scientific Advisor, Research & Early Development, Novo Nordisk

Emily Kramer-Golinkoff

Virtual Speaker

Emily Kramer-Golinkoff

Co-Founder, Emily’s Entourage

Harlan Krumholz, M.D.

Harlan Krumholz, M.D.

Cardiologist and Harold H. Hines, Jr. Professor of Medicine, Yale School of Medicine; Founder and Director of the Yale Center for Outcomes Research and Evaluation (CORE)

Rachel L. Levine, M.D.

Virtual Speaker

Rachel L. Levine, M.D.

Admiral, U.S. Public Health Service, Assistant Secretary for Health, U.S. Department of Health and Human Services

John Maraganore, Ph.D.

John Maraganore, Ph.D.

Founding CEO & Director, Alnylam

Monica McLemore, Ph.D.

Monica McLemore, Ph.D.

Professor and Interim Associate Dean for Equity, Diversity, and Inclusion, University of Washington

Janice Morales-Ferrer

Janice Morales-Ferrer

Patient and Patient Advocate

Mark Parrino

Mark Parrino

President, American Association for the Treatment of Opioid Dependence

Monica Peek, M.D.

Monica Peek, M.D.

Ellen H. Block Professor of Health Justice, Section of General Internal Medicine, The University of Chicago

Abdullah Hasan Pratt, M.D.

Abdullah Hasan Pratt, M.D.

Assistant Professor of Emergency Medicine, Faculty Director of Community Engagement, The University of Chicago Medical Center; Founder of MedCEEP and TRAP Violence

Thomas Robinson, M.D.

Thomas Robinson, M.D.

Irving Schulman, M.D. Endowed Professor in Child Health and Professor of Pediatrics, of Medicine, and, by courtesy, of Epidemiology and Population Health at Stanford University

Rene Salas, M.D.

Rene Salas, M.D.

Emergency Medicine Physician, Center for Social Justice and Health Equity, Department of Emergency Medicine, Massachusetts General Hospital and Harvard Medical School

Marc Succi, M.D.

Marc Succi, M.D.

Associate Chair of Innovation and Commercialization at Mass General Brigham

Jacob S. Van Naarden

Jacob S. Van Naarden

Executive Vice President, Eli Lilly and Company and President, Loxo@Lilly

Zhi Yu, Ph.D.

Zhi Yu, Ph.D.

Postdoctoral Fellow, Broad Institute of MIT and Harvard

Ann E. Woolley, M.D.

Ann E. Woolley, M.D.

Infectious Disease Specialist, Brigham and Women’s Hospital

Brian Alexander, M.D.

Sponsor Speaker

Brian Alexander, M.D.

CEO, Foundation Medicine

Carine Boustany, Ph.D., Pharm.D.

Sponsor Speaker

Carine Boustany, Ph.D., Pharm.D.

SVP, Site Head Discovery Research US & Head of Global Immunology & Respiratory Diseases Research, Boehringer Ingelheim

Kelly Brantley

Sponsor Speaker

Kelly Brantley

Practice Director, Avalere Health

Joshua Cohen

Sponsor Speaker

Joshua Cohen

Co-CEO and Co-Founder, Amylyx Pharmaceuticals

Mat Davis

Sponsor Speaker

Mat Davis

Vice President of Data Science, Jazz Pharmaceuticals

Jeffrey M. Dayno, M.D.

Sponsor Speaker

Jeffrey M. Dayno, M.D.

President and Chief Executive Officer, Harmony Biosciences

James R. Downing, M.D.

Sponsor Speaker

James R. Downing, M.D.

President and Chief Executive Officer, St. Jude Children’s Research Hospital; Member, St. Jude Faculty; Donald Pinkel Chair of Childhood Cancer Treatment

Laura Gault, M.D., Ph.D.

Sponsor Speaker

Laura Gault, M.D., Ph.D.

Chief Medical Officer, Sage Therapeutics

Kevin L. Hagan

Sponsor Speaker

Kevin L. Hagan

President and CEO, PAN Foundation

Edward S. Kim, M.D., M.B.A

Sponsor Speaker

Edward S. Kim, M.D., M.B.A

Vice Physician-in-Chief of City of Hope National Medical Center and the Construction Industries Alliance City of Hope Orange County Physician-in-Chief Chair

Justin Klee

Sponsor Speaker

Justin Klee

Co-CEO and Co-Founder, Amylyx Pharmaceuticals

Kristie Kuhl, J.D.

Sponsor Speaker

Kristie Kuhl, J.D.

Global Managing Partner, Health and Wellness Leader, Zeno Group

Jennifer Keating Litton, M.D.

Sponsor Speaker

Jennifer Keating Litton, M.D.

Vice President, Clinical Research; Professor, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center

Vanessa Procter

Sponsor Speaker

Vanessa Procter

SVP, External Affairs, Sage Therapeutics

Katy Rezvani, M.D., Ph.D.

Sponsor Speaker

Katy Rezvani, M.D., Ph.D.

Professor of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center

Zachary J. Roberts, M.D., Ph.D.

Sponsor Speaker

Zachary J. Roberts, M.D., Ph.D.

Executive Vice President, Research & Development, Chief Medical Officer, Allogene Therapeutics

Carlos Rodriguez-Galindo, M.D.

Sponsor Speaker

Carlos Rodriguez-Galindo, M.D.

Member, St. Jude Faculty; Executive Vice President; Chair, Department of Global Pediatric Medicine; Director, St. Jude Global; Co-Associate Director, Outreach, St. Jude Comprehensive Cancer Center

Kimberly Smith, M.D., MPH

Sponsor Speaker

Kimberly Smith, M.D., MPH

Chief Scientific Officer, Senior Vice President and Head of Research & Development, ViiV Healthcare

Pierre Theodore, M.D.

Sponsor Speaker

Pierre Theodore, M.D.

Executive Director, Patient Impact and Health Equity, Genentech

George Valentine

Sponsor Speaker

George Valentine

Patient Advocate

Rick Berke

Moderator

Rick Berke

Co-Founder and Executive Editor, STAT

Torie Bosch

Moderator

Torie Bosch

Editor, First Opinion, STAT

Laura Chang

Moderator

Laura Chang

Editorial Director, STAT

Angus Chen

Moderator

Angus Chen

Cancer Reporter, STAT

Elaine Chen

Moderator

Elaine Chen

Cardiovascular Disease Reporter, STAT

Rachel Cohrs

Moderator

Rachel Cohrs

Washington Correspondent, STAT

Allison DeAngelis

Moderator

Allison DeAngelis

Biotech Startups and Venture Capital Reporter, STAT

Lev Facher

Moderator

Lev Facher

Addiction Reporter, STAT

Adam Feuerstein

Moderator

Adam Feuerstein

Senior Writer, Biotech, STAT

Damian Garde

Moderator

Damian Garde

National Biotech Reporter, STAT

Gideon Gil

Moderator

Gideon Gil

Managing Editor, STAT

Bob Herman

Moderator

Bob Herman

Business of Health Care Reporter, STAT

Matthew Herper

Moderator

Matthew Herper

Senior Writer, Medicine; Editorial Director of Events, STAT

Lison Joseph

Moderator

Lison Joseph

Equity and Health Tech Editor, STAT

Katherine MacPhail

Moderator

Katherine MacPhail

Programmer, Editorial Events, STAT

Jesse McQuarters

Moderator

Jesse McQuarters

Branded Content Editor, STAT

Usha Lee McFarling

Moderator

Usha Lee McFarling

National Science Correspondent, STAT

Megan Molteni

Moderator

Megan Molteni

Science Writer, STAT

Sarah Owermohle

Moderator

Sarah Owermohle

Washington Correspondent, STAT

Katie Palmer

Moderator

Katie Palmer

Health Tech Correspondent, STAT

Ed Silverman

Moderator

Ed Silverman

Pharmalot Columnist, senior writer, STAT

Nicholas St. Fleur

Moderator

Nicholas St. Fleur

General Assignment Reporter; Associate Editorial Director of Events, STAT

Location

Join us in Boston

The 2023 STAT Summit will take place at the State Room at 60 State Street, Boston, MA or tune in virtually with our cutting edge virtual event platform.

Attending in person and want to stay close by? You can reserve a room at the Canopy by Hilton Boston Downtown.

© Mapbox © OpenStreetMap

Agenda

Join us in Boston, or virtually October 18 – 19.

Agenda and speakers are subject to change. All times listed are EST.

October 18, 2023

7:30 a.m.

Registration Opens

8:00 a.m.

Breakfast Available

9:00 a.m.

Opening from STAT

5 min

9:05 a.m.
Sponsor Session

Welcome Remarks

5 min
James R. Downing, M.D., president and chief executive officer, St. Jude Children’s Research Hospital; member, St. Jude Faculty; Donald Pinkel Chair of Childhood Cancer Treatment

9:10 a.m.

Patient Interstitial: Chronically Catherine

5 min
Catherine Ames, patient & patient advocate

9:15 a.m.

Entrepreneurs In Action

35 min
Vlad Coric, M.D., chairman and CEO, Biohaven Athena Countouriotis, M.D., co-founder, chief executive officer, Avenzo Therapeutics Jacob S. Van Naarden, executive vice president, Eli Lilly and Company and president, Loxo@Lilly Adam Feuerstein, senior writer, biotech, STAT (moderator)

These executives’ successful companies were purchased for billions of dollars. Hear the stories behind the deals, and what’s next for these overachievers and the biotech sector as a whole.

9:50 a.m.

The Story of the GLP-1 Obesity Drugs

25 min
Lotte Bjerre Knudsen, DMSc, chief scientific advisor, Research & Early Development, Novo Nordisk Megan Molteni, science writer, STAT (moderator)

The new medicines for diabetes and obesity are now the biggest thing in medicine. It wasn’t always so. Come hear the 30-year story of one of the first such treatments.

10:15 a.m.
Sponsor Session

Eureka Moment: Quantitative Drug Development

5 min
Mat Davis, head of data science, Jazz Pharmaceuticals

New analytics can change the way drug development is done and breaking down silos across teams allows for critical decisions to inform drug development. Hear how we can efficiently and safely get medicines to patients in need through timely pharmacologic modeling and interconnected data science.

10:20 a.m.

How Lilly Delivered and What’s Next

25 min
Daniel M. Skovronsky, M.D., Ph.D., executive vice president, chief scientific and medical officer, and president, Lilly Research Laboratories, Eli Lilly and Company Matthew Herper, senior writer, medicine; editorial director of events, STAT (moderator)

Eli Lilly is now the world’s first half-trillion-dollar biotech company, in part because of this speaker’s R&D decisions. Find out what’s next for new treatments, including those for Alzheimer’s and obesity.

10:45 a.m.

COFFEE BREAK

25 min

11:10 a.m.

Biotech’s New Power Broker

25 min
John Maraganore, Ph.D., former and founding CEO, Alnylam Pharmaceuticals Allison DeAngelis, biotech startups and venture capital reporter, STAT (moderator)

Since leaving Alnylam Pharmaceuticals, where he took a technology from Nobel Prize to marketed drug, John Maraganore has been indefatigable, with his hands in one company after another. He’s everywhere – so he’ll probably talk about everything in drug development.

11:35 a.m.
Sponsor Session

Advancing the Next Wave of Cancer Breakthroughs

10 min
Katy Rezvani, M.D., Ph.D., professor of stem cell transplantation & cellular therapy, The University of Texas MD Anderson Cancer Center Nicholas St. Fleur, general assignment reporter; associate editorial director of events, STAT (moderator)

Yes, cell therapies have transformed the cancer treatment landscape, but it’s only the beginning. A pioneer in a new type of cell therapy, based on ‘natural killer’ cells, discusses the future of the field, what it takes to advance a risky idea, and the importance of early-career scientists in groundbreaking research.

11:45 a.m.

Introducing the 2023 STAT Wunderkinds

35 min
Brenda Cabrera-Mendoza, M.D., Ph.D., postdoctoral fellow, Yale University Lauren Ghazal, Ph.D., assistant professor, University of Rochester Medical Center Zhi Yu, Ph.D., postdoctoral fellow, Broad Institute of MIT and Harvard Katherine MacPhail, programmer, editorial events, STAT (moderator)

Hear from the next generation of scientific superstars and this year’s class of STAT Wunderkinds. They’ll discuss their groundbreaking work on renal disease, the genetics of psychiatric disorders, and the effects of financial toxicity on health.

12:20 p.m.

LUNCH

40 min

1:00 p.m.
Sponsor Session

Breakout Session | New Analysis: How Medicare Reforms Change Patient Behavior

45 min
Kelly Brantley, practice director, Avalere Health Kevin L. Hagen, president and CEO, PAN Foundation George Valentine, patient advocate

Be the first to hear a new analysis exploring how historic Medicare Part D reforms could change adherence to treatment. Also, learn why many people on Medicare Part D will continue to turn to charitable patient assistance foundations for support.

1:00 p.m.
Sponsor Session

Breakout Session | CEO Deep – Dive: Now and Next in our Industry

45 min
Joshua Cohen, co-CEO and co-founder, Amylyx Pharmaceuticals Jeffrey Dayno, M.D., president and chief executive officer, Harmony Biosciences Justin Klee, co-CEO and co-founder, Amylyx Pharmaceuticals Kristie Kuhl, J.D., global managing partner, health and wellness leader, Zeno Group

A visit with three of the most interesting people in biotech. We’ll talk about finding solutions for medical needs, bringing the dream of making drug development patient-centered, and looking ahead to what could happen in biopharma over the next few years.

1:45 p.m.

Transition From Breakout Sessions

15 min

2:00 p.m.

A Poet Faces a Chronic Disease

25 min
Meghan O’Rourke, author of “The Invisible Kingdom: Reimagining Chronic Illness” Angus Chen, cancer reporter, STAT (moderator)

Meghan O’Rourke has long been recognized as one of the most talented stylists of her generation. Her most recent book grapples with her experience of an autoimmune disease, and has thoughtful perceptions on how medicine should change.

2:25 p.m.
Sponsor Session

A Turning Point for High-Quality Diagnostics in Cancer

10 min
Brian Alexander, M.D., CEO, Foundation Medicine Gideon Gil, managing editor, STAT (moderator)

Increasingly, physicians are using genomic tests to match the right patient to the right treatment at the right time. But precision cancer care can only be as good as the tests used to guide diagnosis and treatment. As our understanding of cancer improves, new regulatory reforms could make it harder to fulfill the promise of precision cancer by disincentivizing high-quality genomic testing.

2:35 p.m.

Patient Interstitial: A Brain Computer Interface

5 min
Ian Burkhart, founder, BCI Pioneers Coalition

2:40 p.m.

Funding the Next Generation of Breakthroughs

30 min
Priscilla Chan, M.D., co-founder and co-CEO, Chan Zuckerberg Initiative Mark Zuckerberg, co-founder and co-CEO, Chan Zuckerberg Initiative Rick Berke, co-founder and executive editor, STAT (moderator)

The Chan Zuckerberg Initiative has a bold goal: to help scientists cure, prevent, or manage all disease. Hear why the organization’s billionaire founders and namesakes believe this seemingly impossible goal is achievable and what they have accomplished so far.

3:10 p.m.
Sponsor Session

Curing the Incurable

10 min
James R. Downing, M.D., president and chief executive officer, St. Jude Children’s Research Hospital; member, St. Jude Faculty; Donald Pinkel Chair of Childhood Cancer Treatment Matthew Herper, senior writer, medicine; editorial director of events, STAT

3:20 p.m.

Rethinking the Way America Treats Addiction

30 min
Zoe Adams, M.D., resident physician and writer, Department of Medicine, Massachusetts General Hospital Aaron Ferguson, leadership team, community medical services research committee and outreach manager, National Survivors Union Mark Parrino, president, American Association for the Treatment of Opioid Dependence Lev Facher, addiction reporter, STAT (moderator)

Methadone is the most effective drug available to treat opioid use disorder, but U.S. law makes it nearly impossible to access. With overdoses at an all-time high, some experts say it is time to radically deregulate medication-assisted treatment.

3:50 p.m.

COFFEE BREAK

20 min

4:10 p.m.

Fighting the Hospital System’s Opaque Pricing Practices

25 min
Cynthia Fisher, founder and chairman, PatientRightsAdvocate.org Rachel Cohrs, Washington Correspondent, STAT (moderator)

Why is it that in medicine, patients cannot find out what something will cost? Hear how one philanthropist is fighting the impenetrable thicket of health care pricing with celebrities as her weapon.

4:35 p.m.
Sponsor Session

Unlocking the Fourth Great Wave in Cancer Treatment

10 min
Zachary J. Roberts, M.D., Ph.D., executive vice president, research & development, chief medical officer, Allogene Therapeutics Laura Chang, editorial director, STAT (moderator)

CAR-Ts are changing the treatment of cancer. But struggles to meet patient demand strain the system, a problem that will worsen as more patients become eligible. What’s needed? An “off-the-shelf” CAR T product that can unlock the promise and democratize access to this powerful fourth wave of cancer treatment.

4:45 p.m.

Dana-Farber’s Big Plan

25 min
Craig Bunnell, M.D., chief medical officer, Dana-Farber Cancer Institute Laurie Glimcher, M.D., president and CEO, Dana-Farber Cancer Institute; Richard and Susan Smith Professor of Medicine, HMS Bob Herman, business of health care reporter, STAT (moderator)

The news that the iconic cancer center would end its longtime relationship with Brigham and Women’s Hospital to create a new hospital with Beth Israel Deaconess surprised the medical world. Dana-Farber’s CEO argues it is better for patients and for Boston.

5:10 p.m.

Demo: Doctor vs. ChatGPT

25 min
Marc Succi, M.D., associate chair of innovation and commercialization at Mass General Brigham Ann E. Woolley M.D., infectious disease specialist, Brigham and Women’s Hospital Katie Palmer, health tech correspondent, STAT (moderator)

We’ll give both an infectious disease expert and an AI interface information about a patient case. Who will make the right diagnosis, the bot or the doc?

5:35 p.m.
Sponsor Session

Closing Remarks

5 min
Jennifer Keating Litton, M.D., vice president, clinical research; professor, department of breast medical oncology, The University of Texas MD Anderson Cancer Center

5:40 p.m.

Closing From STAT

5 min

5:45 p.m.

Networking Reception

90 min
Brought to you by 2023 STAT Wunderkinds Sponsor, The University of Texas MD Anderson Cancer Center

7:00 p.m.

Afterparty: Celebrating STAT Wunderkinds

Join us at the Wunderkinds After Party! At this event attendees can meet this year’s class of Wunderkinds, as well as Wunderkinds Alumni, STAT reporters, and enjoy free food and drinks. The party will be hosted at arcade bar VERSUS, located at 42 Province St, Boston, MA 02108.

October 19, 2023

7:30 a.m.

Registration Opens

8:00 a.m.

Breakfast Available

8:45 a.m.

Opening from STAT

5 min

8:50 a.m.

The Readout LOUD, Live!

30 min
Allison DeAngelis, biotech startups and venture capital reporter, STAT Adam Feuerstein, senior writer, biotech, STAT Damian Garde, national biotech reporter, STAT

Your favorite guides to all things biotech — live in person! Delve into the latest news in this special edition of the weekly podcast series.

9:20 a.m.

Patient Interstitial: Environmental Racism

5 min
Monique Fitzgerald, community advocate; council member of the Setalcott Nation; co-founder of the Brookhaven Landfill Action and Remediation Group

9:25 a.m.

What Will it Take to End the Crisis of Black Deaths?

35 min
Harlan Krumholz, M.D., cardiologist and Harold H. Hines, Jr. Professor of Medicine, Yale School of Medicine; founder and director of the Yale Center for Outcomes Research and Evaluation (CORE) Monica McLemore, Ph.D., professor and interim associate dean for equity, diversity, and inclusion, University of Washington Monica Peek, M.D., Ellen H. Block Professor of Health Justice, section of general internal medicine, The University of Chicago Usha Lee McFarling, national science correspondent, STAT (moderator)

In the last two decades, Black Americans have suffered 1.63 million excess deaths and lost more than 80 million years of life compared to white Americans. How do we fix this?

10:00 a.m.
Sponsor Session

Where East Meets West: The Next Frontier of Integrative Oncology

10 min
Ed Kim, M.D, M.B.A, vice physician-in-chief of City of Hope National Medical Center and the Construction Industries Alliance City of Hope Orange County Physician-in-Chief Chair Torie Bosch, editor, First Opinion, STAT (moderator)

Patient demand for integrative therapies is on the rise. Yet, despite thousands of years of use and experience with Eastern treatments, few health care organizations provide access to them. City of Hope shares how integrative oncology can be interwoven into the standard of care, improving outcomes and quality of life for cancer patients and survivors.

10:10 a.m.

GSK’s New Groove

25 min
Emma Walmsley. chief executive officer, GSK Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)

After years of waiting, the British drug giant has shed its consumer division and renewed its focus with the launch of a new vaccine for RSV, an infection that causes serious illness in older people. Hear about what’s ahead.

10:35 a.m.
Sponsor Session

Beyond Buzzwords: Health Equity and Inclusive Research in Action

10 min
Pierre Theodore, M.D., executive director, patient impact and health equity, Genentech Lison Joseph, equity and health tech editor, STAT (moderator)

Since launching the first ever clinical trial focused exclusively on understanding how multiple sclerosis impacts Black and Hispanic/Latinx people, Genentech has continued to listen, learn, act, and partner to make research more representative and healthcare more equitable in MS and other serious diseases. Hear about this journey.

10:45 a.m.

Facing the Firearm Injury Crisis

20 min
Abdullah Hasan Pratt, M.D., assistant professor of emergency medicine, faculty director of community engagement, The University of Chicago Medical Center; founder of MedCEEP and TRAP Violence Usha Lee McFarling, national science correspondent, STAT (moderator)

When Abdullah Pratt was finishing his first year of medical school, his older brother, Rashad, was shot and killed. Now, he fights to preserve other lives, as an emergency medicine physician and by training thousands in health emergency response skills.

11:05 a.m.

COFFEE BREAK

25 min

11:30 a.m.

Patient Interstitial: Coverage Denied

5 min
Janice Morales, patient and patient advocate

11:35 a.m.

Fixing the Health Care System

25 min
Amy Finkelstein, Ph.D., John & Jennie S. MacDonald Professor of Economics, MIT Bob Herman, business of health care reporter, STAT (moderator)

A simple, tough message: the U.S. healthcare system can’t be renovated. This is a tear-down. Here’s what universal basic health care coverage could look like and how it might work.

12:00 p.m.
Sponsor Session

We Can End the HIV Epidemic – Why Haven’t We?

10 min
Kimberly Smith, M.D., MPH, chief scientific officer, senior vice president and head of research & development, ViiV Healthcare Jesse McQuarters, branded content editor, STAT (moderator)

The HIV epidemic is now 40 years old. Science and innovation have given us many of the tools to end it, so why is HIV still a thing? Hear about the five things we could do now to end the epidemic.

12:10 p.m.

How New is the New Biogen?

25 min
Christopher Viehbacher, CEO, Biogen Matthew Herper, senior writer, medicine; editorial director of events, STAT

Biogen faced a bruising failure in Alzheimer’s drug development. But now a veteran CEO is aiming to remake the company, powered by a share of an Alzhimer’s drug that is on the market and a new strategy. Hear his plan.

12:35 p.m.

Why STAT?

5 min
Linda Henry, CEO, Boston Globe Media Partners

12:40 p.m.

LUNCH

60 min

1:40 p.m.

A Conversation with Michael J. Fox

30 min
Deborah W. Brooks, CEO and co-founder, The Michael J. Fox Foundation for Parkinson’s Research Michael J. Fox , award-winning actor, best-selling author, and founder of the Michael J. Fox Foundation for Parkinson’s Research Matthew Herper, senior writer, medicine; editorial director of events, STAT (moderator)

He’s a bestselling author, an optimist, and, of course, an icon. Here’s how Michael J. Fox has used his fame to accelerate research and drug development in Parkinson’s disease. Hear the latest about his “business that’s aiming to go out of business,” including a new biomarker that may pave the way for future advances.

2:10 p.m.
Sponsor Session

Driving Breakthroughs at Boehringer Ingelheim

10 min
Carine Boustany, Ph.D., Pharm.D. SVP, site head discovery research US & head of global immunology & respiratory diseases research, Boehringer Ingelheim Rick Berke, co-founder and executive editor, STAT (moderator)

Patients have counted on Boehringer Ingelheim for breakthroughs for over 138 years, resulting in diverse treatments for cardio-renal-metabolic diseases, oncology, immunology, rare diseases, respiratory illnesses and mental health. Hear more about the magic in this independent company’s unique approach to innovation.

2:20 p.m.

Building Biology’s Century

20 min
Noubar Afeyan, Ph.D., founder and CEO, Flagship Pioneering Matthew Herper, senior writer, medicine; editorial director of events, STAT

Flagship Pioneering has been one of the most important company creators of the biotech revolution, with big failures and even bigger successes. Hear how the machine works from the man who built it.

2:40 p.m.
Sponsor Session

A Call to Action on Maternal Mental Health

10 min
Laura Gault, M.D., Ph.D., chief medical officer, Sage Therapeutics Vanessa Procter, SVP, external affairs, Sage Therapeutics Jesse McQuarters, branded content editor, STAT (moderator)

The public is increasingly aware of the mental health challenges that can accompany pregnancy and childbirth. New treatments could elevate the standard of care, and public policies can increase their impact. Critical challenges remain. Here’s why we must act with urgency to create a better future for maternal mental health.

2:50 p.m.

COFFEE BREAK

20 min

3:10 p.m.

Patient Interstitial: When Cystic Fibrosis Drugs Don’t Work

5 min
Emily Kramer-Golinkoff, co-founder, Emily’s Entourage

3:15 p.m.

Protecting Our Health From Climate Change

30 min
Adm. Rachel L. Levine, M.D., admiral, U.S. Public Health Service; assistant secretary for health, U.S. Department of Health and Human Services (Virtual) Renee Salas, M.D., emergency medicine physician, Center for Social Justice and Health Equity, department of emergency medicine, Massachusetts General Hospital and Harvard Medical School Sarah Owermohle, Washington correspondent, STAT (moderator)

Over the coming decades warming climates will present a growing problem for health care. We’ll look at how the health care industry can prepare, and at its role in cutting greenhouse emissions.

3:45 p.m.

Patient Interstitial: One Person’s GLP-1 Experience

5 min
Faith Anne Heeren, doctoral candidate, University of Florida

3:50 p.m.

What’s Next for Obesity Drugs?

30 min
Angela Fitch, M.D., co-founder and chief medical officer, knownwell Stacie Dusetzina, Ph.D., professor of health policy, Vanderbilt University School of Medicine Thomas Robinson, M.D., Irving Schulman, M.D. Endowed Professor in Child Health and Professor of Pediatrics, of Medicine, and, by courtesy, of Epidemiology and Population Health at Stanford University Elaine Chen, cardiovascular disease reporter, STAT (moderator)

What does the future of a world with obesity drugs look like? GLP-1s are changing the landscape of obesity medicine. What do these treatments mean for the drug market and for combating the environmental drivers of obesity?

4:20 p.m.
Sponsor Session

Closing Remarks

5 min
Carlos Rodriguez-Galindo, M.D., member, St. Jude Faculty; executive vice president, and chair, Department of Global Pediatric Medicine; director, St. Jude Global; co-associate director, outreach, St. Jude Comprehensive Cancer Center

4:25 p.m.

Closing From STAT

5 min
Rick Berke, co-founder and executive editor, STAT

4:30 p.m.

Closing Reception

90 min

Open to all STAT Summit attendees!

 

Check out the 2022 STAT Summit

Sponsors

A special thanks to our sponsors

Presenting Sponsor

STAT Wunderkinds Sponsor

Premium Sponsors

Supporting Sponsor

Contact

Stay in the loop

Join our email list

Sign up today for summit news and updates

Questions?

Contact us at [email protected] with any questions or to register as press

Terms & Conditions